Tasly Pharmaceutical Group Co., Ltd
Clinical trials sponsored by Tasly Pharmaceutical Group Co., Ltd, explained in plain language.
-
Could herbal pills cut eye injections for wet AMD? new trial launches
Disease control Not yet recruitingThis phase 3 trial tests whether adding Sanhuang Jingshiming Pills (a traditional Chinese herbal medicine) to standard ranibizumab injections can reduce the number of injections needed for wet age-related macular degeneration. About 450 adults aged 50-85 with active wet AMD will …
Phase: PHASE3 • Sponsor: Tasly Pharmaceutical Group Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New depression pill JS1-1-01 enters key trials
Symptom relief Not yet recruitingThis study tests an experimental tablet called JS1-1-01 in 180 adults with moderate to severe depression. Participants will take either a low dose, high dose, or placebo for 8 weeks. The goal is to see if the drug safely reduces depression symptoms better than a placebo.
Phase: PHASE2, PHASE3 • Sponsor: Tasly Pharmaceutical Group Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC